×

Network disruptions

We have been experiencing disruptions on our local network which has affected the stability of these web pages. We have been working with IT support team to get this fixed as a matter of urgency and apologise for any inconvenience.

View in Gene3D

CATH Superfamily 2.40.128.200

C-type lysozyme inhibitor

The name of this superfamily has been modified since the most recent official CATH+ release (v4_4_0). At the point of the last release, this superfamily was: waiting to be named.

Functional Families

Overview of the Structural Clusters (SC) and Functional Families within this CATH Superfamily. Clusters with a representative structure are represented by a filled circle.

Superfamily: C-type lysozyme inhibitor

Lysozymes are the first line of defense for a diverse range of organisms that catalyse the degradation of bacterial peptidoglycan. Gram-negative bacteria produce proteinaceous lysozyme inhibitors to protect themselves from the action of lysozymes. Membrane-bound (MliC) or periplasmic (PliC) versions of this inhibitor have been identified in Gram-negative bacteria. This entry represents the structure of this inhibitor which is a slightly flattened beta-barrel PMID:24308818.

GO Diversity

Unique GO annotations
5 Unique GO terms

EC Diversity

Unique EC annotations
0 Unique EC terms

Species Diversity

Unique species annotations
2550 Unique species

Sequence/Structure Diversity

Overview of the sequence / structure diversity of this superfamily compared to other superfamilies in CATH. Click on the chart to view the data in more detail.

Superfamily Summary

A general summary of information for this superfamily.
Structures
Domains: 16
Domain clusters (>95% seq id): 9
Domain clusters (>35% seq id): 3
Unique PDBs: 6
Alignments
Structural Clusters (5A): 1
Structural Clusters (9A): 1
FunFam Clusters: 2
Function
Unique EC:
Unique GO: 5
Taxonomy
Unique Species: 2550
CATH-Gene3D is a Global Biodata Core Resource Learn more...